Toxins 99, new information about the botulinum neurotoxins.
Carruthers
A
A
Carruthers
J
J
D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans
D018726:Anti-Dyskinesia Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A